St. Stefan ob Stainz

Austria

6 total trials 3 recruiting

Filter these 6 trials by phase, condition, sponsor and more.

Open in Search →

A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney D … Recruiting

2025-523123-22-00 5 2026-05-07 Chronic Kidney Disease
ZENITH: Zilebesiran in Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk … Recruiting

2025-522960-34-00 5 2026-02-09 Established cardiovascular disease
Phase III study to evaluate the effect of balcinrenone/dapagliflozin in patients with heart failure and impaired kidney function Recruiting

2023-508162-15-00 5 2024-07-12 Chronic HF and comorbid impairment of kidney function who had a recent
HERMES – A research study to look at how ziltivekimab works compared to placebo in people with heart failure and inflammation. Ended recruitment

2022-501939-16-00 5 2023-05-09 Heart failure (HF) with mildly reduced ejection fraction (HFmrEF) or H
Research study on whether semaglutide works in people with non-alcoholic steatohepatitis (NASH) Ended recruitment

2023-506962-30-00 5 2021-03-29 Non-alcoholic steatohepatitis (NASH)
A research study to see how well CagriSema helps people with type 2 diabetes and excess body weight lose weight Ended

2023-506931-13-00 5 2023-01-30 Overweight and obesity and type 2 diabetes

Showing 1–6 of 6 trials